North America Coronary and Peripheral Stents Market Outlook (2022-2033)

The North America coronary and peripheral stents market size is expected to reach US$ 9,685.7 million by 2033 from US$ 4,276.3 million in 2024. The market is estimated to record a CAGR of 9.7% from 2025 to 2033.

Executive Summary and North America Coronary and Peripheral Stents Market Analysis:

The North America coronary and peripheral stents market is one of the most established globally, characterized by advanced healthcare infrastructure, high physician expertise, and widespread adoption of cutting‑edge stent technologies. The region benefits from strong reimbursement frameworks, extensive clinical research, and rapid integration of innovations such as drug‑eluting and bioresorbable stents. The United States dominates the market, leveraging its large patient population, robust hospital networks, and leadership in medical device innovation. Growth is driven by rising cardiovascular disease prevalence, aging demographics, and increasing demand for minimally invasive procedures. However, restraints include cost‑containment pressures, regulatory complexities, and disparities in access between urban and rural populations. Despite these challenges, North America remains a critical hub for global stent development and adoption, with the U.S. setting benchmarks in clinical practice, technology integration, and procedural volumes, reinforcing its leadership in shaping worldwide cardiovascular intervention trends.

North America Coronary and Peripheral Stents Market Segmentation Analysis

Key segments that contributed to the derivation of the coronary and peripheral stents market analysis are product type, material type, application and end user.

• By product type, the coronary and peripheral stents market is segmented into bare-metal stents, drug-eluting stents, bioresorbable vascular scaffolds, and others. The drug-eluting stents segment dominated the market in 2024. Superior efficacy in reducing restenosis, longer-term patient outcomes, and widespread physician preference drove adoption, making them the most trusted choice compared to bare-metal or bioresorbable alternatives.
• By material type, the coronary and peripheral stents market is segmented into metal, polymer, and hybrid. The metal segment dominated the market in 2024. High durability, proven biocompatibility, cost-effectiveness, and established clinical success ensured dominance, as polymer and hybrid options remain limited in availability, scalability, and long-term performance validation.
• By application, the coronary and peripheral stents market is segmented into coronary artery disease and peripheral artery disease. The coronary artery disease segment dominated the market in 2024. Higher global prevalence, significant clinical burden, and greater demand for interventional procedures positioned coronary stents as the leading application, overshadowing peripheral artery disease interventions in overall market share.
• By end user, the market is segmented into hospitals, ambulatory surgical centers, cardiac catheterization labs, and specialty clinics. The hospitals segment held the largest share of the market in 2024. Comprehensive infrastructure, advanced catheterization facilities, skilled specialists, and ability to handle complex cases ensured hospitals remained the primary setting for stent implantation, surpassing smaller clinics and ambulatory centers.

North America Coronary and Peripheral Stents Market Outlook

The North American market is mature, with coronary drug‑eluting stents and nitinol peripheral stents firmly established as standards of care. Hospitals, specialty cardiovascular centers, and outpatient facilities drive procurement, supported by structured reimbursement systems and guideline‑based treatment pathways. A key driver is the region’s strong clinical research ecosystem, particularly in the United States, where extensive trials and academic collaborations accelerate innovation and adoption. This research strength ensures rapid evaluation of new stent technologies, enabling physicians to integrate advanced devices into practice with confidence. Clinical studies not only validate safety and efficacy but also influence reimbursement decisions, fostering widespread utilization. The research‑driven environment encourages manufacturers to launch new products in North America first, reinforcing its role as a testing ground for global innovation. This driver sustains market growth by continuously refreshing product portfolios and ensuring alignment with evolving cardiovascular treatment standards.

North America Coronary and Peripheral Stents Market Country Insights

Based on country, the North America coronary and peripheral stents market is further segmented into the United States, Canada and Mexico. The United States held the largest share in 2024.

The United States dominates the North American coronary and peripheral stents market, supported by its large patient population, advanced healthcare infrastructure, and leadership in medical device innovation. The country’s extensive hospital networks and specialized cardiovascular centers ensure high procedural volumes, with drug‑eluting stents widely adopted as the gold standard. Peripheral stent usage is also expanding, driven by rising awareness of peripheral artery disease32 and availability of advanced nitinol solutions. U.S. dominance is reinforced by strong reimbursement frameworks, centralized procurement in major hospital systems, and active participation in clinical trials that shape global guidelines. Multinational leaders such as Abbott, Boston Scientific, and Medtronic are headquartered or heavily invested in the U.S., ensuring rapid access to new technologies. With continuous investment in R&D, physician training, and infrastructure, the United States sets the benchmark for coronary and peripheral stent utilization, shaping both regional and global adoption trends.

North America Coronary and Peripheral Stents Market Company Profiles

Medtronic, Boston Scientific Corporation, Abbott, B. Braun SE, TERUMO CORPORATION, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co. Ltd., Cook Medical, Meril Life Sciences and Translumina are among the key players operating in the market. These players adopt strategies such as expansion, product innovation, and mergers and acquisitions to stay competitive in the market and offer innovative products to their consumers.

North America Coronary and Peripheral Stents Market Research Methodology:

The following methodology has been followed for the collection and analysis of data presented in this report:

• Secondary Research

The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

• Primary Research

Business Market Insights conducts a significant number of primary interviews each year with industry stakeholders and experts to validate and analyze the data and gain valuable insights. These research interviews are designed to:

• Refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews with industry experts across various markets, categories, segments, and sub-segments in different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise

North America Coronary and Peripheral Stents Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• European Society of Cardiology
• American College of Cardiology
• American Heart Association
• Asian Pacific Society of Interventional Cardiology
• Company website
• Company annual reports
• Company investor presentations